by Amy Berger | Apr 19, 2022 | News, Publications and Press
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. Our team here at IITRI was contracted to perform in vitro testing of their drug candidates for antiviral effects against multiple strains of SARS-CoV-2 as well as cytotoxicity....
by Amy Berger | Feb 25, 2022 | Uncategorized
DECADES OF EXPERTISE. IITRI has performed carcinogenicity studies in rodent models for over 40 years. We have been a major preclinical contractor to the National Cancer Institute for decades, and our scientists are known as leaders in carcinogenicity evaluation and in...
by Amy Berger | Feb 15, 2022 | Events, News
We’re excited to be attending the 61st Annual Meeting and ToxExpo (March 27-31, 2022) in sunny San Diego after two years of delayed and virtual meetings. You can find us at the Expo at Booth #2307 from March 28-30 in the Exhibit Hall (ground level) from 9am-...
by Amy Berger | Aug 24, 2021 | Blog, News
August is National Immunization Awareness Month (NIAM) which serves as reminder of the importance of vaccination for people of all ages. We’re proud to play a role in the development and testing of vaccines here at IITRI. IITRI has decades of experience...
by Amy Berger | Jul 26, 2021 | Blog, News
STARTING OFF ON THE RIGHT FOOT Our inhalation services include preliminary method development activities as the necessary first step for inhalation toxicology studies. The selection and characterization of the test atmosphere to be realistic and extensively measured...
Recent Comments